In a first, US clears AstraZeneca antibody for long-term prevention against COVID-19 infection
The AstraZeneca antibody-drug cleared by the US Food and Drug Administration on Wednesday is different. It's the first authorised for long-term prevention against COVID-19 infection, rather than short-term treatment.
Dec 09, 2021, 07:52 AM IST